Search
for
Sort by
Research 751–780 of 1000+
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- Laser Capture Microdissection Reveals Transcriptional Abnormalities in Alopecia Areata before, during, and after Active Hair Loss
- Tofacitinib in the Recalcitrant Cases of Alopecia Areata: A Pilot Study
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- 6ER-014 Evaluation of baricitinib in paediatric patients with alopecia areata
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Review of Promising Off-Label Use of Deucravacitinib
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- Transcriptome analysis of frontal fibrosis alopecia revealed involvement of immune cells and ferroptosis
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Application of Baricitinib in Dermatology
- Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Deciphering the molecular drivers for cashmere/pashmina fiber production in goats: a comprehensive review
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Bletilla striata polysaccharide-based dissolving microneedle patch integrated with nanoparticles for promoting hair regrowth
- Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review